Connor, Clark & Lunn Investment Management Ltd.
Position in OPK — Opko Health, Inc.
CIK 1596800
VANCOUVER, A1
Position in OPK
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$596,112
+$53,519 QoQ
Shares Held
522,906
+21.4% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in OPK Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $206,312,128 across 18 Diagnostics & Research names. OPK ranks #18 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
134,838 | $64,747,859 | |
| 2 | ILMN |
Illumina, Inc.
|
202,742 | $24,989,978 | |
| 3 | DHR |
Danaher Corp /De/
|
129,426 | $24,539,169 | |
| 4 | GH |
Guardant Health, Inc.
|
254,788 | $23,534,767 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
54,570 | $9,413,325 | |
| 6 | CSTL |
Castle Biosciences Inc
|
377,082 | $9,257,363 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
649,627 | $9,016,822 | |
| 8 | NEO |
Neogenomics Inc
|
938,052 | $6,960,345 |
All Filings in OPK
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $596,112 | 522,906 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $542,593 | 430,630 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $608,779 | 392,761 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $516,996 | 391,664 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $334,232 | 201,345 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $32,781 | 22,300 | Shares | Sole | 2025-02-10 | |
| 2023-12-31 | $2,323,461 | 1,538,716 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,271,931 | 1,419,957 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,369,902 | 1,092,121 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,300,027 | 890,430 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,023,280 | 818,624 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,431,183 | 757,240 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,327,293 | 524,622 | Shares | Sole | 2022-08-05 | |
| 2021-12-31 | $3,018,053 | 627,454 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,610,324 | 989,130 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,246,062 | 801,497 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $514,049 | 119,825 | Shares | Sole | 2021-05-13 | |
| 2020-03-31 | $842,628 | 628,827 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||